Market Analysis — NEW LONDON HOSPITAL
NH market | 5 hospitals | HHI: nan (Competitive)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
5
Hospitals in Market
490
Total Beds
$0.7B
Market Revenue
Competitive
HHI: nan
None
Moat Rating (1/10)
#2
Market Share Rank
Competitive Moat (Mauboussin Framework)
Based on "Measuring the Moat" adapted for healthcare. Score 0-10: wide (8+), narrow (5-7), none (<5).
Scale Advantageweak
Switching Costslow
Market Share12.5%
Top 3 Concentration95.9%
Network Density1.02
Margin vs Market-3.4%
Bed Util vs Market+0.3%
What This Means
This hospital has a none moat — no moat — commoditized market position, pricing power limited. The NH market is competitive — many players, value creation must come from operations not market power (HHI: nan).
Implications: Operational improvements are the primary value driver — see the EBITDA bridge. Compare against peers via comparables or see the full NH market.
Top Competitors
| Hospital | Beds | Revenue | Rev Share | Bed Share |
|---|---|---|---|---|
| CONCORD HOSPITAL INC. | 206 | $554M | 78.8% | 42.0% |
| ENCOMPASS HEALTH REHABILITATION HOSP | 50 | $32M | 4.5% | 10.2% |
| CONCORD HOSPITAL - FRANKLIN | 25 | $29M | 4.1% | 5.1% |
| NEW HAMPSHIRE HOSPITAL | 184 | $nanM | nan% | 37.5% |
Regional Payer Mix
■ Medicare 34%■ Medicaid 12%■ Commercial 54%